Clinical Trial Update: MGC018 With or Without MGA012 in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from the combination of MGC018 with or without MGA012 (pembrolizumab) in advanced solid tumors. The Phase 1/2 study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Head and Neck Squamous Cell Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• MGA012 (MGA012)
• MGC018

Snippet

Sponsor: MacroGenics | Conditions: Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-07-31